Search results for "SRA"

showing 10 items of 349 documents

Frequent use of sugar products by schoolchildren in 20 European countries, Israel and Canada in 1993/1994

1999

The aim of this study was to describe the daily use of certain between-meal sugar products (soft drinks and sweets) of schoolchildren in 20 European countries, Israel and Canada as a part of the Cross-National Survey on Health Behaviour in School-Aged Children--a WHO Collaborative Study. The data were collected using standardised anonymous questionnaires in school classrooms during the 1993/1994 school year. In each country nationally or regionally representative samples of about 1,300 schoolchildren (450 in Greenland) were targeted. Use of sugar products was analysed according to sex, age, country, self-reported school performance and self-reported family economy. One third to one half of …

MaleCanadaAdolescentHealth BehaviorFrequency of useEthnic groupCarbonated BeveragesNorthern irelandWorld Health OrganizationSocial classCandyFamily economySex FactorsDietary SucroseSurveys and QuestionnairesEthnicityOdds RatioHumansIsraelChildSocioeconomicsGeneral DentistryAge FactorsReproducibility of ResultsOral health promotionFeeding BehaviorAchievementFrequent useEuropeGeographySchool performanceSocial ClassFemaleInternational Dental Journal
researchProduct

Limited cross-border infections in patients newly diagnosed with HIV in Europe

2013

Background: International travel plays a role in the spread of HIV-1 across Europe. It is, however, not known whether international travel is more important for spread of the epidemic as compared to endogenous infections within single countries. In this study, phylogenetic associations among HIV of newly diagnosed patients were determined across Europe.Results: Data came from the SPREAD programme which collects samples of newly diagnosed patients that are representative for national HIV epidemics. 4260 pol sequences from 25 European countries and Israel collected in 2002-2007 were included.We identified 457 clusters including 1330 persons (31.2% of all patients). The cluster size ranged bet…

MaleEpidemiologyHuman immunodeficiency virus (HIV)Human immunodeficiency virus 1HIV Infectionsmedicine.disease_causeVirologie généralephylogenySettore MED/42 - Igiene Generale E ApplicataMen who have sex with menEMERGENCE0302 clinical medicineMedicine and Health SciencesMedicineInfection controlCluster Analysis030212 general & internal medicineIsraelPathologie maladies infectieusestravelPhylogeny0303 health sciencesMolecular EpidemiologyTravelTransmission (medicine)articlevirus transmissionIMMUNODEFICIENCY-VIRUS TYPE-13. Good healthPeer reviewEuropefemaleInfectious DiseasesSUBTYPE BDRUG-RESISTANT HIV-1RNA Viralmale homosexualAdultstructural geneMolecular Sequence DataNewly diagnosedClusters03 medical and health sciencesmaleSDG 3 - Good Health and Well-beingMOLECULAR EPIDEMIOLOGYSWITZERLANDVirologygeographic distributionHumansTransmissionIn patienthuman030304 developmental biologynonhumanMolecular epidemiologybusiness.industryResearchhigh risk populationVirologie médicalenucleotide sequenceSequence Analysis DNAHuman immunodeficiency virus 1 infectionVirologymajor clinical studyunindexed sequence3121 General medicine internal medicine and other clinical medicineHIV-1businessEurope HIV-1 Transmission ClustersDemographycluster analysis
researchProduct

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

2008

BACKGROUND: The spread of drug-resistant HIV-1 might compromise the future success of current first-line regimens. OBJECTIVE: To analyse the extent and impact of transmission of drug-resistant HIV-1 variants in Europe. DESIGN AND METHODS: The European prospective programme (SPREAD) collected demographic, clinical and virological data from 1245 HIV-1-infected individuals in 17 countries diagnosed in 2002-2003. The potential impact of transmitted drug resistance mutations (TDRMs) on therapy response was determined by using genotypic interpretation algorithms. RESULTS: The overall prevalence of viruses with drug-resistance mutations was 9.1% [96/1050; 95% confidence interval: 7.5-11.1]. The ma…

MaleGenes Viralmedicine.medical_treatmentResistanceHuman immunodeficiency virus (HIV)hiv-1HIV InfectionsDrug resistanceSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeNucleoside Reverse Transcriptase InhibitorGenotypePrevalenceImmunology and AllergyHIV InfectionIsraelriskimmunodeficiency-virus type-1Transmission (medicine)transmissionpersistenceMiddle AgedReverse Transcriptase InhibitorEuropeInfectious Diseasesprimary infectionReverse Transcriptase InhibitorsFemaleeuropeHumanAdultRiskGenotypeLogistic ModelprevalenceImmunologyBiologyresistanceSDG 3 - Good Health and Well-beingDrug Resistance ViralDisease Transmission InfectiousmedicineHumansTransmissionHIV Protease Inhibitortime trendstherapyChi-Square DistributionProteaseHIV Protease InhibitorsloadmutationsVirologyConfidence intervalReverse transcriptaseLogistic ModelsDisease Transmission InfectiouMutationHIV-1AIDS
researchProduct

A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16

2008

As part of the International Multi-centre ADHD Gene (IMAGE) project we have completed an affected sibling pair study of 142 narrowly defined DSM-IV combined type ADHD proband-sibling pairs. We found suggestive linkage on chromosomes 9 and 16 with non-parametric multipoint peak LOD scores of 2.13 and 3.1 respectively. There have been several previous ADHD linkage scans. The UCLA study (Fisher et al. 2002; Ogdie et al. 2004; Ogdie et al. 2003), the Dutch study (Bakker et al. 2003), the German study (Hebebrand et al. 2006) and the MGH Study (Faraone et al., submitted) applied the affected sib pair (ASP) strategy; the Columbian study used extended pedigrees ascertained from a population isolate…

MaleGenetics and epigenetic pathways of disease [NCMLS 6]GENOMEWIDE SCANMedizin2804 Cellular and Molecular NeuroscienceCHILDRENComorbidityNeuroinformatics [DCN 3]Severity of Illness IndexDevelopmental psychology2738 Psychiatry and Mental Health0302 clinical medicinePerception and Action [DCN 1]HETEROGENEITYIsraelChildGeneticsObserver Variation0303 health sciencesATTENTION-DEFICIT/HYPERACTIVITY DISORDERPSYCHIATRIC-DISORDERSDOPAMINE TRANSPORTER GENEASSOCIATION10058 Department of Child and Adolescent PsychiatryEuropePsychiatry and Mental healthFemalePsychologyChromosomes Human Pair 9linkageFunctional Neurogenomics [DCN 2]GenotypeDEFICIT HYPERACTIVITY DISORDER610 Medicine & healthPolymorphism Single NucleotideMental health [NCEBP 9]Genetic determinismWhite PeopleGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesCellular and Molecular NeuroscienceCognitive neurosciences [UMCN 3.2]Genetic linkage1312 Molecular BiologymedicineSNPAttention deficit hyperactivity disorderHumansADHDSiblingMolecular Biology030304 developmental biologyLinkage (software)SiblingsChromosomemedicine.diseaseSib pairsUnited Statesaffected sib pairsGenetic defects of metabolism [UMCN 5.1]Attention Deficit Disorder with HyperactivityCONDUCT DISORDERLod ScoreDISEQUILIBRIUM030217 neurology & neurosurgeryChromosomes Human Pair 16
researchProduct

Population differences in the International Multi-Centre ADHD Gene Project.

2008

Contains fulltext : 71443.pdf (Publisher’s version ) (Closed access) The International Multi-Centre ADHD Gene sample consists of 674 families from eight countries (Belgium, England, Germany, Holland, Ireland, Israel, Spain, and Switzerland) ascertained from clinics for combined-type attention definity hyperactivity disorder in an offspring. 863 SNPs were successfully genotyped across 47 autosomal genes implicated in psychiatric disorders yielding a single nucleotide polymorphism (SNP) density of approximately one SNP per 2.5 kb. A global test of heterogeneity showed 269 SNPs nominally significant (expected 43). Inclusion of the Israeli population accounted for approximately 70% of these nom…

MaleLinkage disequilibriumInternationalityGenetics and epigenetic pathways of disease [NCMLS 6]EpidemiologyMedizinNeuroinformatics [DCN 3]Linkage Disequilibrium0302 clinical medicineGene FrequencyPerception and Action [DCN 1]International HapMap ProjectIsraelChildGenetics (clinical)0303 health scienceseducation.field_of_studyChromosome MappingSDG 10 - Reduced Inequalities10058 Department of Child and Adolescent PsychiatryGeographyChild Preschool/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesFemaleFunctional Neurogenomics [DCN 2]Genetic Markers2716 Genetics (clinical)AdolescentPopulationSample (statistics)Single-nucleotide polymorphism610 Medicine & healthMental health [NCEBP 9]Polymorphism Single NucleotideWhite PeopleGenomic disorders and inherited multi-system disorders [IGMD 3]03 medical and health sciencesCognitive neurosciences [UMCN 3.2]SNPHumansddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendalterseducationGene030304 developmental biologyGenetic VariationGenetics PopulationGenetic defects of metabolism [UMCN 5.1]HaplotypesSample size determinationAttention Deficit Disorder with Hyperactivity030217 neurology & neurosurgeryDemography2713 Epidemiology
researchProduct

International Physical Activity and Built Environment Study of Adolescents : IPEN Adolescent design, protocol and measures

2021

IntroductionOnly international studies can provide the full variability of built environments and accurately estimate effect sizes of relations between contrasting environments and health-related outcomes. The aims of the International Physical Activity and Environment Study of Adolescents (IPEN Adolescent) are to estimate the strength, shape and generalisability of associations of the community environment (geographic information systems (GIS)-based and self-reported) with physical activity and sedentary behaviour (accelerometer-measured and self-reported) and weight status (normal/overweight/obese).Methods and analysisThe IPEN Adolescent observational, cross-sectional, multicountry study …

MaleNEIGHBORHOOD ENVIRONMENTstatistics & research methodsWalkingOverweightCardiovascularOral and gastrointestinal0302 clinical medicineresearch methodsBelgiumResidence CharacteristicsInformed assentResearch MethodsMedicine and Health SciencesMedicineSOCIOECONOMIC-STATUS030212 general & internal medicine1506IsraelBuilt EnvironmentAetiologyChildBuilt environmentCzech RepublicCancerPediatricBangladeshpublic healthSEDENTARY BEHAVIORGeneral MedicineStrokeYOUTHWalkabilityRELIABILITYPublic Health and Health ServicesHong KongFemaleepidemiologySCHOOL-AGED CHILDRENHEALTHPSYCHOSOCIAL FACTORSmedicine.symptomsocial and economic factorsBrazilPediatric Research InitiativeAdolescentInternational studiesClinical SciencesNigeriaIndiapreventive medicine03 medical and health sciencesYoung Adult2.3 PsychologicalEnvironmental healthHumansObesitySocioeconomic statusExerciseMetabolic and endocrineNutritionOBJECTIVE ASSESSMENTWALKABILITY SCALEOther Medical and Health SciencesPortugalbusiness.industry1730PreventionMalaysiaAustralia030229 sport sciencesCross-Sectional StudiesSpainSurvey data collectionObservational studyEnvironment Designstatistics &ampbusinessNew Zealand
researchProduct

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in pat…

2013

Abstract Background This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric junction. Methods Patients received neoadjuvant radiotherapy (50.4 Gy) together with weekly docetaxel (20 mg/m2 at dose level (DL) 1 and 2, 25 mg/m2 at DL 3) and oxaliplatin (40 mg/m2 at DL 1, 50 mg/m2 at DL 2 and 3) over 5 weeks. The primary endpoint was the DLT and the MTD of the RCT regimen. Secondary endpoints included overall response rate (ORR) and progression-free survival (PFS). Results A total of 24 patients were included. F…

MaleOncologyCancer ResearchTime FactorsEsophageal NeoplasmsOrganoplatinum Compoundsmedicine.medical_treatmentMedizinKaplan-Meier EstimateDocetaxellaw.inventionRandomized controlled triallawGermanyProspective StudiesIsraelProspective cohort studyNeoadjuvant therapyChemoradiotherapyMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensNeoadjuvant TherapyOxaliplatinOesophagogastric cancer oxaliplatinTreatment OutcomeDocetaxelOncologyNeoadjuvant radiochemotherapyAdenocarcinomaFemaleTaxoidsEsophagogastric JunctiontherapeuticsResearch Articlemedicine.drugAdultmedicine.medical_specialtyMaximum Tolerated DoseAntineoplastic AgentsAdenocarcinomalcsh:RC254-282Disease-Free SurvivalStomach NeoplasmsInternal medicinemedicineGeneticsHumansddc:610neoplasmsAgedDose-Response Relationship Drugbusiness.industryChemoradiotherapy Adjuvantmedicine.diseasedigestive system diseasesOxaliplatinClinical trialbusinessChemoradiotherapy
researchProduct

Occupational solvent exposure and risk of glioma in the INTEROCC study

2017

BACKGROUND: The aetiology of glioma remains largely unknown. Occupational solvent exposure has been suggested as a putative cause of glioma, but past studies have been inconsistent. We examined the association between a range of solvents and glioma risk within the INTEROCC project, a study of brain tumours and occupational exposures based on data from seven national case-control studies conducted in the framework of the INTERPHONE study. We also investigated associations according to tumour grade.METHODS: Data from the seven countries were standardised and then combined into one aggregate data set. Pooled odds ratios (ORs) were estimated for adjusted models that included sex, age, country-r…

MaleOncologyMESH: United KingdomCancer ResearchEpidemiology[SDV]Life Sciences [q-bio]MESH: Neoplasm GradingMESH: SolventsMESH: Occupational ExposureMESH: GliomaTumor gradechemistry.chemical_compound0302 clinical medicineRisk FactorsMESH: New ZealandMESH: Risk FactorsGermanyOdds RatioIsraelYoung adultMESH: AgedOccupationMESH: Middle AgedBrain NeoplasmsAge FactorsMESH: IsraelGliomaMiddle Aged030210 environmental & occupational healthMESH: Case-Control Studies3. Good healthOncologyMESH: Young Adult030220 oncology & carcinogenesisSolventMESH: Brain NeoplasmsFemaleFranceAdultCanadamedicine.medical_specialtyAdolescentCase–control studyJob-exposure matrixMESH: AustraliaYoung Adult03 medical and health sciencesSex FactorsMESH: Sex FactorsMESH: CanadaOccupational ExposureInternal medicineGliomamedicineJournal ArticleHumansMESH: GermanyAgedMESH: AdolescentMESH: Age FactorsMESH: Humansbusiness.industryAustraliaCase-control studyMESH: AdultOdds ratiomedicine.diseaseUnited KingdomConfidence intervalMESH: MaleMESH: Odds RatioMESH: FrancechemistryCase-Control StudiesSolventsNeoplasm GradingSolvent exposurebusinessMESH: FemaleNew Zealand
researchProduct

Trends in multiple recurrent health complaints in 15-year-olds in 35 countries in Europe, North America and Israel from 1994 to 2010

2015

Background: Health complaints are a good indicator of an individual’s psychosocial health and well-being. Studies have shown that children and adolescents report health complaints which can cause significant individual burden. Methods: Using data from the international Health Behaviour in School-aged Children study, this article describes trends in multiple recurrent health complaints (MHC) in 35 countries among N = 237 136 fifteen-year-olds from 1994 to 2010. MHC was defined as the presence of two or more health complaints at least once a week. Logistic regression analysis was performed to evaluate trends across the five survey cycles for each country. Results: Lowest prevalence thro…

MalePediatricsmedicine.medical_specialtyAdolescentHealth StatusAdolescent HealthLogistic regressionPrevalenceHumansMedicineIsraelhealth and well-beingSchool age childbusiness.industryEnvironmental and Occupational HealthPublic Health Environmental and Occupational HealthInternational healthta3141ta3142BenchmarkingHealth SurveysQuadratic trendEuropeNorth AmericaFemalePublic Healthtrend analysisHealth behaviorbusinessPsychosocialDemographyThe European Journal of Public Health
researchProduct

Trends in health complaints from 2002 to 2010 in 34 countries and their association with health behaviours and social context factors at individual a…

2015

BACKGROUND: This article describes trends and stability over time in health complaints in adolescents from 2002 to 2010 and investigates associations between health complaints, behavioural and social contextual factors at individual level and economic factors at macro-level.METHODS: Comprising N = 510 876 11-, 13- and 15-year-old children and adolescents in Europe, North America and Israel, data came from three survey cycles of the international Health Behaviour in School-aged Children (HBSC) study. Age- and gender-adjusted trends in health complaints were examined in each country by means of linear regression. By using the country as the random effects variable, we tested to what extent in…

MalePediatricsmedicine.medical_specialtyAdolescentSocial Determinants of HealthHealth BehaviorMEDLINEsocial contextual factorshealth complaintshealth behaviourEnvironmental healthmedicineMacro levelHealth Status IndicatorsHumansadolescentsSocial determinants of healthIsraelChildAssociation (psychology)School age childeconomic factorsbusiness.industryEnvironmental and Occupational HealthPublic Health Environmental and Occupational HealthSocial environmentta3141ta3142Health SurveysEuropeAdolescent BehaviorNorth AmericaFemalePublic HealthHealth behaviorbusiness
researchProduct